3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Genitourinary
1
Dermatologic
1
Conditions
Breast Neoplasms
25
Uterine Cervical Neoplasms
6
Melanoma
5
Endometrial Neoplasms
5
Mouth Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Vulvar Neoplasms
2
Uterine Neoplasms
2
Triple Negative Breast Neoplasms
2
Rectal Neoplasms
2
Lymphatic Metastasis
2
Head and Neck Neoplasms
2
Recurrence
1
Recurent Vulvar Carcinoma
1
Penile Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Node-positive Breast Cancer
1
Neoplasm Micrometastasis
1
Neoplasm Metastasis
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cervical Adenocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal
1
Carcinoma
1
Breast Neoplasms, Male
1
Breast Carcinoma In Situ
1
Interventions
Ultrasonography
1
Surveys and Questionnaires
1
Sildenafil Citrate
1
Sentinel Lymph Node Biopsy
1
Psychiatric Rehabilitation
1
Psychiatric Nursing
1
Physical Therapy Modalities
1
Early Intervention, Educational
1
Counseling
1
Alprostadil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Penile Neoplasms
×
Sentinel Lymph Node Biopsy
×
Clear all
NCT06666634
2024-10-30
NANOSCAN
The Netherlands Cancer Institute
Phase NA
Recruiting
29 enrolled